Navigation Links
DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients
Date:10/11/2010

CLEVELAND, Oct. 11 /PRNewswire/ -- The preeminent law office of Nurenberg, Paris, Heller & McCarthy has filed a class action lawsuit against Johnson & Johnson's artificial joint replacement company DePuy Orthopaedics, Inc., on behalf of clients who suffered damages resulting from the company's now-recalled hip replacement device.  (Case No. 1:10CV02222, U.S. District Court, Northern District of Ohio, Eastern Division)

"Revision" Surgeries RequiredDePuy recently recalled two hip replacement products -- the ASR Hip Resurfacing System and the ASR XL Acetabular System -- after data showed that within five years, one in eight patients needed "revision surgeries," which are required when an artificial joint doesn't properly fit or breaks down prematurely. About 93,000 people around the world have received one of these potentially faulty hip implants.

The legal professionals at Nurenberg, Paris, Heller & McCarthy expect the class action lawsuit to include hundreds, if not thousands, of victims. Headed by attorney David M. Paris, the lawsuit is seeking to assist those who have received a DePuy ASR hip implant and experienced pain, had problems walking, or needed a revision surgery to fix a faulty hip implant.

"We're working to get the victims of faulty DePuy hip implants the help they need," said Paris, partner at Nurenberg, Paris, Heller & McCarthy. "The rights, remedies, and needs of each victim are unique and require special attention. As a result, we're conducting a full-scale investigation and have assembled a team of physicians, nurses, and other experts who will be working on behalf of the victims of this disastrous medical device."

Hip Replacement Patients Deceived about CostsThe claim states that DePuy required patients to release their confidential medical records to even be considered for reimbursement of medical costs. As a result, some patients may have been misled into believing DePuy had actually agreed to advance or reimburse costs for medical monitoring and revision procedures when, in fact, DePuy's intent was only to use the medical information to determine if any costs should be reimbursed to patients. Furthermore, these medical releases allow DePuy to gain access to the removed hip replacement devices for testing purposes while denying the test results from the respective patients and their own healthcare experts. Consequently, crucial evidence is prevented from reaching those affected by the defective products.

DePuy Class Action InvolvementNurenberg, Paris, Heller & McCarthy is currently accepting cases on behalf of those who have been affected by the DePuy hip replacement recall and resulting medical issues. Class members involved in this claim may be entitled to the following:

  • payment and/or reimbursement for revision surgeries
  • economic and non-economic damages
  • medical monitoring procedures by caregivers, which include radiographic evaluation, blood testing for cobalt and chromium ion levels, and MRI or ultrasound examinations
  • an injunction to prohibit DePuy from communicating with plaintiffs and class members through their physicians

  • To learn more about DePuy's recall of its ASR Hip Resurfacing System and ASR XL Acetabular System, call Nurenberg, Paris, Heller & McCarthy at (800) 562-7438 or visit www.nphm.com.

    About Nurenberg, Paris, Heller & McCarthyNurenberg, Paris, Heller & McCarthy is a nationally recognized law office that has served the needs of catastrophically injured clients throughout the United States since 1928. Nurenberg Paris is a Cleveland, Ohio-based law firm known for its success in cases involving defective products, class action litigation, medical malpractice, wrongful death, airplane crashes, railroad crossing collisions, unfair business practices, and insurance. The trial lawyers at Nurenberg Paris have been admitted to practice law in courts across the country and pride themselves on their long-standing history of achieving justice for clients in the trial and appellate courts. For more information, visit www.nphm.com.  For more information, contact:Tamara BriningerPhone: (216) 694-5204E-mail: TBrininger@nphm.com
    '/>"/>

    SOURCE Nurenberg, Paris, Heller & McCarthy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
    2. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
    3. DePuy Orthopaedics Voluntarily Recalls ASR™ Hip System
    4. Materialise Launches SurgiCase(R) Orthopaedics: A Comprehensive, Custom Solution That Assures Best Practices For The Orthopaedic Surgeon
    5. Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System
    6. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
    7. Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries
    8. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
    9. Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
    10. Clinical Trial Establishes Catheter-Based Aortic Valve Replacement as New Standard of Care for Patients Who Cannot Undergo Surgery
    11. Patients Should Expect Long Life from their Joint Replacements!
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
    (Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
    (Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
    Breaking Medicine Technology:
    (Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
    (Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
    (Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
    (Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
    (Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
    Breaking Medicine News(10 mins):